MARC

LEADER 00000cam a2200000 a 4500
001 SCIDIR_ocn566265191
003 OCoLC
005 20231117032944.0
006 m o d
007 cr bn||||||abp
007 cr bn||||||ada
008 100322s1985 enka ob 001 0 eng d
040 |a OCLCE  |b eng  |e pn  |c OCLCE  |d OCLCQ  |d UIU  |d OCLCF  |d N$T  |d YDXCP  |d E7B  |d EBLCP  |d DEBSZ  |d OCLCQ  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d STF  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCA  |d OCLCQ  |d OCLCO  |d OCL  |d OCLCQ 
019 |a 605635763  |a 896795476  |a 899002963  |a 974616058  |a 1100915763  |a 1154489345 
020 |a 9781483162980  |q (electronic bk.) 
020 |a 1483162982  |q (electronic bk.) 
020 |z 9780407023017 
020 |z 0407023011 
035 |a (OCoLC)566265191  |z (OCoLC)605635763  |z (OCoLC)896795476  |z (OCoLC)899002963  |z (OCoLC)974616058  |z (OCoLC)1100915763  |z (OCoLC)1154489345 
042 |a dlr 
050 4 |a RG556 
060 4 |a WQ 200  |b D7937 1985 
072 7 |a MED  |x 033000  |2 bisacsh 
082 0 4 |a 618.3/061  |2 19 
245 0 0 |a Drug therapy during pregnancy /  |c edited by Tom K.A.B. Eskes and Mieczyslaw Finster. 
260 |a London ;  |a Boston :  |b Butterworths,  |c 1985. 
300 |a 1 online resource (x, 230 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Butterworths international medical reviews. Obstetrics and gynecology 
504 |a Includes bibliographical references and index. 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2010.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2010  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
588 0 |a Print version record. 
505 0 |a Front Cover; Drug Therapy During Pregnancy; Copyright Page; Preface; Contributors; Table of Contents; Chapter 1. Prospective study of the use of medication during pregnancy in the Netherlands; INTRODUCTION; MATERIAL AND METHODS; RESULTS; DISCUSSION; CONCLUSION; Acknowledgements; References; Chapter 2. Pharmacotherapy during pregnancy: emphasis on pharmacokinetics; INTRODUCTION; THE INFLUENCE OF PHYSIOLOGICAL CHANGES IN PREGNANCY ON PHARMACOKINETIC PARAMETERS; KINETIC CONSIDERATIONS FOR DOSAGE ADJUSTMENT IN PREGNANCY; ASPECTS OF FETAL DRUG EXPOSURE; CONCLUSION; References. 
505 8 |a Chapter 3. Drugs and environmental agents in the pathogenesis of congenital malformationsENVIRONMENTAL AGENTS; CONCLUSION; Acknowledgements; References; Chapter 4. Hypertension and pregnancy; INTRODUCTION; NORMAL AND ABNORMAL BLOOD PRESSURE DURING PREGNANCY; TYPES OF HYPERTENSIVE DISORDERS; CARDIOVASCULAR DYNAMICS OF HYPERTENSION DURING PREGNANCY; PHARMACOLOGIC TREATMENT OF HYPERTENSION DURING PREGNANCY; EFFECT OF ANTIHYPERTENSIVE THERAPY ON THE MATERNAL PROGNOSIS; EFFECT OF ANTIHYPERTENSIVE TREATMENT ON UTERINE BLOOD FLOW; EFFECT OF ANTIHYPERTENSIVE THERAPY ON THE FETUS AND NEONATE. 
505 8 |a RECOMMENDATIONS FOR CURRENT TREATMENTReferences; Chapter 5. Non-steroidal anti-inflammatory agents; PHARMACOLOGY; PLACENTAL TRANSFER AND KINETICS; ADMINISTRATION AND INGESTION DURING PREGNANCY; GENERAL FETAL EFFECTS; FETAL EFFECTS THROUGH INHIBITION OF PHYSIOLOGIC FUNCTION; CONCLUSION; Acknowledgements; References; Chapter 6. Antiepileptics; DIPHENYLHYDANTOIN; VALPROIC ACID; DIAZEPAM; CARBAMAZEPINE; BARBITURATES; MAGNESIUM SULFATE; TERATOGENICITY; CONCLUSION; References; Chapter 7. Hormonal therapy during pregnancy; THYROID AND ANTITHYROID DRUGS; SEX HORMONES; Summary; CORTICOSTEROIDS. 
505 8 |a INSULINReferences; Chapter 8. Anesthesia during pregnancy and parturition; PERINATAL PHARMACOLOGY; SURGICAL ANESTHESIA DURING PREGNANCY; PRACTICAL CONSIDERATIONS; References; Chapter 9. Stimulation of uterine activity; INTRODUCTION; OXYTOCIN; PROSTAGLANDINS; CONCLUSION; Acknowledgement; References; Chapter 10. The use of beta-adrenergic drugs in obstetrics; INTRODUCTION; CLINICAL APPLICATION OF BETA-ADRENERGIC DRUGS IN PRETERM LABOR; MATERNAL EFFECTS; FETAL EFFECTS; NEONATAL EFFECTS; CONCLUSION; References; Chapter 11. Drugs and fetal heart rate patterns; INTRODUCTION. 
505 8 |a DRUGS THAT REDUCE FETAL HEART RATE VARIABILITYDRUGS THAT ENHANCE FETAL HEART RATE VARIABILITY; COMMENTS; References; Chapter 12. Reproductive and developmentaltoxicology; INTRODUCTION; REPRODUCTIVE TOXICITY IN THE FEMALE; PREIMPLANTATION TOXICITY; PLACENTAL TOXICITY; FETAL TOXICITY/TRANSPLACENTAL CARCINOGENICITY; CONCLUSIONS; Acknowledgements; References; Index. 
520 |a Drug Therapy During Pregnancy. 
650 0 |a Pregnant women. 
650 0 |a Chemotherapy. 
650 0 |a Pregnancy. 
650 2 |a Drug Therapy  |0 (DNLM)D004358 
650 2 2 |a Pregnancy  |0 (DNLM)D011247 
650 2 |a Pregnant Women  |0 (DNLM)D037841 
650 6 |a Femmes enceintes.  |0 (CaQQLa)201-0027856 
650 6 |a Chimioth�erapie.  |0 (CaQQLa)201-0034750 
650 6 |a Grossesse.  |0 (CaQQLa)201-0012998 
650 7 |a pregnancy.  |2 aat  |0 (CStmoGRI)aat300189669 
650 7 |a MEDICAL  |x Gynecology & Obstetrics.  |2 bisacsh 
650 7 |a Pregnancy.  |2 fast  |0 (OCoLC)fst01075102 
650 7 |a Chemotherapy.  |2 fast  |0 (OCoLC)fst00853595 
650 7 |a Pregnant women.  |2 fast  |0 (OCoLC)fst01075191 
650 7 |a Femmes enceintes  |x Usage des m�edicaments.  |2 ram 
650 7 |a Pharmacologie gyn�ecologique et obst�etricale.  |2 ram 
653 |a Pregnant women  |a Drug therapy. 
700 1 |a Eskes, T. K. A. B.  |q (Tom Kees Anton Bonifacius) 
700 1 |a Finster, Mieczyslaw. 
776 0 8 |i Print version:  |t Drug therapy during pregnancy.  |d London ; Boston : Butterworths, 1985  |w (OCoLC)13558723 
830 0 |a Butterworths international medical reviews. Obstetrics and gynecology. 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780407023017  |z Texto completo